4 articles
Famous Labs launched Heisenberg, a quantum-informed AI platform that integrates electron-density molecular representations with ADMET and synthesis data to optimize molecule prioritization in drug discovery.
Isomorphic Labs unveiled IsoDDE, an AI drug design engine that more than doubles AlphaFold 3's accuracy in protein-ligand prediction and identifies novel binding pockets from sequence alone, as the company prepares for its first clinical trials.
The LIGAND-AI consortium launched with over 60 million euros in EU funding, bringing 18 partners led by Pfizer and the SGC together to generate open datasets of protein-ligand interactions for training AI drug discovery models.
NVIDIA and Eli Lilly announced a $1 billion AI co-innovation lab in South San Francisco, combining Lilly's pharmaceutical expertise with NVIDIA's BioNeMo platform and Blackwell-powered supercomputing to reinvent drug discovery.